Effects of lipid lowering by atorvastatin on carotid atherosclerotic plaque (ACAP) study: a randomized trial for analysis of qualitative change in carotid atherosclerrotic plaque with IB [integrated backscatter] echo and Black Blood MRI [magnetic resonance imaging]

Trial Profile

Effects of lipid lowering by atorvastatin on carotid atherosclerotic plaque (ACAP) study: a randomized trial for analysis of qualitative change in carotid atherosclerrotic plaque with IB [integrated backscatter] echo and Black Blood MRI [magnetic resonance imaging]

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2013

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Acronyms ACAP
  • Most Recent Events

    • 06 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top